In cancers such as lung cancer, gastric cancer, colorectal cancer, glioblastoma, and prostate cancer, HMGCR is often highly expressed, and this high expression correlates with poorer overall survival in patients (23–25). Here, HMGCR is linked to colorectal cancer.